Form 4: GRI Bio: Vipin Chaturvedi's Stock Option Grant
SEC Form 4
Vipin Chaturvedi, Chief Scientific Officer of GRI Bio, Inc., reports the acquisition of stock options.
Summary
- Vipin Chaturvedi, Chief Scientific Officer of GRI Bio, Inc., was granted stock options on September 18, 2025.
- The stock options grant is for 43,222 shares of common stock at an exercise price of $1.93.
- 29,923 shares vested immediately, and 13,299 shares will vest in 12 equal quarterly installments over three years.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The grant of stock options to a key executive is generally viewed as a positive sign, indicating confidence in the company's future prospects.
Positives
- Grant of stock options to the Chief Scientific Officer, aligning his interests with the company's success.
- Immediate vesting of a significant portion of the options (29,923 shares) provides immediate incentive.
- The remaining options vest over three years, incentivizing long-term commitment.
Future Outlook
The filing does not contain any specific forward-looking statements or guidance.
Industry Context
Stock option grants are a common practice in the biotechnology industry to incentivize key executives and align their interests with shareholders.
Stakeholder Impact
- Shareholders: Aligns management's interests with shareholder value.
- Employees: May improve morale by demonstrating investment in leadership.
- Management: Incentivizes key personnel to achieve company goals.
Key Dates
| Date | Description |
|---|---|
| 09/18/2025 | Date of stock option grant |
| 09/18/2035 | Expiration date of the stock options |
| 09/22/2025 | Date of signature on the Form 4 filing |
Keywords
stock options, GRI Bio, Vipin Chaturvedi, Chief Scientific Officer, SEC Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.